When analysing the opportunities and risks regarding products or portfolios, or when optimizing processes at the data level – an independent perspective is often lacking. The data are available. But what do they mean? Cognotekt will support you in understanding information from all domains. It will allow you to obtain the highest transparency when turning data into objective decisions.
New: Follow our “Biopharma series“.
We evaluate designs and results during all phases in pharmaceutical and medical technology product development – from the preclinical stage (translational medicine), to clinical studies in phases 1 to 3, on through to indication expansions, lifecycle management and post-authorization studies (phase 4). We analyse the evidence regarding individual products, and we put these results in the context of market forecasts and the competitive situation. You gain a comprehensible and clear decision-making basis for your next steps.
We analyse opportunities for utilizing AI and IT systems to their full potential for healthcare providers. We assist in integrating digital infrastructure into existing IT landscapes. Using long-term experience with IT systems in medicine, expertise in patient care, and regulatory frameworks, we provide well-funded decision-making guidance. We offer evaluation, design, and implementation of automation technologies for your healthcare facility.
We analyse the multidimensional processes and requirements in your research and development pipelines, determine pain points and assist you in developing clear steps towards an optimised process and system architecture.
Data-driven processes and AI applications are complex. We create transparency. We evaluate the quality of the models and the type of data management, identify the potential for improvement and advise you on the selection of entirely new solutions and on their implementation.
Cognotekt was launched in 2013 as a consulting company for sophisticated data- and research-driven sectors. It focuses on linking life science with data analytics; its customers are mainly biotech and pharmaceuticals companies, as well as medical product manufacturers and healthcare providers. They include Labor Berlin, BetterDoc and MedGate. With its combination of data analysis, in-depth industry know-how and independence, Cognotekt is an objective advisor for strategically relevant decisions.
Founder and partner
Physician, biochemist and mathematician
25 years’ professional experience in biochemistry, medicine, biomathematics; life science consulting, AI and IT
Key focus:
Life science, product and portfolio
Partner
Former Professor of Linguistics at the University of Hamburg
Ten years of experience in management consulting and linguistics
Key focus:
Business processes and organisation
Partner
IT expert
15 years’ experience in software development and architecture, IT, data science and AI
Key focus:
Life science IT, data science, AI
Before we can successfully analyse figures and correlations, they have to be prepared in a targeted way, going from the raw data, to the machine-readable data set, through to the data-driven findings. It is precisely these steps that are the task of Daniel Beck: “Data doesn’t lie – at least not when it is collated in full and analysed. I work with our customers to gather their data in its entirety and to use the insights that are gained to achieve a greater level of profitability.”
What challenge
are you facing? Write to us.
Dr. Raija Kramer
info@cognotekt.com
+49 221-643065-10